Rate of Cognitive Decline in Preclinical Alzheimer's Disease: The Role of Comorbidity
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
We investigated the influence of individual-difference variables implicated as risk factors for Alzheimer's disease (AD) or known to be related to cognitive performance in normal aging (e.g., age, sex, years of education, previous and recent diseases, apolipoprotein E status, social network, and substance use) on rate of cognitive change from preclinical to clinical AD. With the use of data from a population-based study, 230 persons who were nondemented at baseline and diagnosed with AD at a 3-year follow-up were examined with the Mini-Mental State Examination (MMSE). Of all predictor variables examined, only number of diseases resulting in hospital admission during the follow-up period made an independent contribution to rate of MMSE change. These results suggest that many variables affecting the onset of the degenerative process as well as cognitive functioning in normal aging exert little influence on rate of cognitive change in preclinical AD. This may reflect the fact that the emerging dementia disease overshadows the role of these variables for cognitive functioning. A possible exception to this pattern is that an increasing number of concomitant health conditions may exacerbate the rate of cognitive decline during the final portion of the preclinical phase in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726
Influence of social network on occurrence of dementia: a community-based longitudinal study
Fratiglioni, L., Wang, H.-X., Ericsson, K., Maytan, M., & Winblad, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02113-9 · Cited by 1,361
Self-citationThe Preclinical Phase of Alzheimer Disease: A 22-Year Prospective Study of the Framingham Cohort
Elias, M. F., Beiser, A., Wolf, P. A., Au, R., White, R. F., & D'Agostino, R. B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.808 · Cited by 716 · cited 2×
“In most of these studies, the retest interval has been approximately 3 years, although preclinical cognitive deficits in AD have been documented by using follow-up periods of more than 10 years (Elias et al., 2000; La Rue & Jarvik, 1987).”
BackgroundFratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A., & Winblad, B. (1997) · Neurology · doi:10.1212/wnl.48.1.132 · Cited by 556
Self-citationFratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., Grafström, M., Holmen, K., Ericsson, K., Bäckman, L., Ahlbom, A., & Winblad, B. (1991) · Neurology · doi:10.1212/wnl.41.12.1886 · Cited by 525
Self-citationNeuropsychological prediction of dementia and the absence of dementia in healthy elderly persons
Masur, D. M., Sliwinski, M., Lipton, R. B., Blau, A. D., & Crystal, H. A. (1994) · Neurology · doi:10.1212/wnl.44.8.1427 · Cited by 422
Neuropsychological detection and characterization of preclinical Alzheimer’s disease
Jacobs, D. M., Sano, M., Dooneief, G., Marder, K., Bell, K. L., & Stern, Y. (1995) · Neurology · doi:10.1212/wnl.45.5.957 · Cited by 409
The Smarter Sex: A Critical Review of Sex Differences in Intelligence
Halpern, D. F., & LaMay, M. L. (2000) · Educational Psychology Review · doi:10.1023/a:1009027516424 · Cited by 321 · cited 1×
“…emerging evidence of an increased risk of late-onset AD in women compared with men (e.g., Fratiglioni et al., 1997; Fratiglioni, Launer, et al., 2000), although sex differences in global cognitive ability are small or nonexistent in normal aging (e.g., Halpern & LaMay, 2000; Hill & Bäckman, 1995).”
BackgroundBondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999) · Psychology and Aging · doi:10.1037//0882-7974.14.2.295 · Cited by 235
Cited by
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis
Bäckman, L., Jones, S., Berger, A.-K., Laukka, E. J., & Small, B. J. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.4.520 · Cited by 735
Self-citationAnstey, K. J., Mack, H. A., & Cherbuin, N. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a2fd07 · Cited by 452
Amieva, H., Mokri, H., Le Goff, M., Meillon, C., Jacqmin-Gadda, H., Foubert-Samier, A., Orgogozo, J.-M., Stern, Y., & Dartigues, J.-F. (2014) · Brain · doi:10.1093/brain/awu035 · Cited by 295
Multiple cognitive deficits during the transition to Alzheimer's disease
Bäckman, L., Jones, S., Berger, A. ‐., Laukka, E. J., & Small, B. J. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01386.x · Cited by 291
Self-citationClinical features and multidisciplinary approaches to dementia care
MacDonald, S., Grand, & Caspar (2011) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s17773 · Cited by 254
Metadata
- Authors
- Bäckman, L., Jones, S., Small, B. J., Agüero-Torres, H., & Fratiglioni, L.
- Venue
- The Journals of Gerontology: Series B
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07-01
- Volume
- 58
- Issue
- 4
- Pages
- P228-P236
- ISSN
- 1079-5014 (ISSN-L)
- 1758-5368
- OpenAlex
- W2170866276
- Cited by
- 66
- References
- 12
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rate of Cognitive Decline in Preclinical Alzheimer's Disease: The Role of Comorbidity. https://app.cochat.ai/papers/10.1093/geronb/58.4.p228
- The paper
- Bäckman, L., Jones, S., Small, B. J., Agüero-Torres, H., & Fratiglioni, L. (2003). Rate of Cognitive Decline in Preclinical Alzheimer's Disease: The Role of Comorbidity. The Journals of Gerontology: Series B. https://doi.org/10.1093/geronb/58.4.p228
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.